Examples of using Sofosbuvir in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
without cirrhosis receiving 12 weeks of simeprevir+ sofosbuvir achieved SVR12 table 16.
Co-administration of Sovaldi with medicinal products that inhibit P-gp and/or BCRP may increase sofosbuvir plasma concentration without increasing GS-331007 plasma concentration,
In subjects with ESRD, relative to subjects with normal renal function, sofosbuvir AUC0-inf was 28% higher when sofosbuvir was dosed 1 hour before haemodialysis compared with 60% higher when sofosbuvir was dosed 1 hour after haemodialysis.
Cases of severe bradycardia and heart block have been observed when sofosbuvir used in combination with another direct acting antiviral,
6a were used for testing sofosbuvir.
Weeks OLYSIO+ sofosbuvir.
The active substance is sofosbuvir.
Sofosbuvir activity EC50, nM.
Sofosbuvir is a nucleotide prodrug.
Daclatasvir in combination with sofosbuvir.
The predominant circulating metabolite of sofosbuvir.
The active substances are ledipasvir and sofosbuvir.
Harvoni contains the active substances ledipasvir and sofosbuvir.
Each film-coated tablet contains 400 mg of sofosbuvir.
No dose adjustment of sofosbuvir or methadone is.
Sofosbuvir has been authorised as Sovaldi since January 2014.
Mg/ sofosbuvir(400 mg once daily)d.
See also under Use with ledipasvir and sofosbuvir below.
Sofosbuvir is a nucleotide prodrug that is extensively metabolised.
Sofosbuvir 400 mg once daily daclatasvir 60 mg once daily.